The honest headline is that MOTS-c's side-effect profile in humans is not established. No adequately powered human clinical trials of administered MOTS-c exist, so there is no trial-based safety dataset to summarize. Almost all evidence comes from cell and mouse studies, where the focus was metabolic effect rather than a human adverse-event profile.[1][2]
Reviewed for accuracy · Last reviewed July 7, 2026What little community reporting exists describes mostly local effects, such as injection-site irritation, with occasional mentions of fatigue or headache. Because that reporting is anecdotal and the underlying human evidence is sparse and correlational, none of it should be read as a validated safety profile. This is one of the thinner side-effect pictures among researched peptides, and that uncertainty is the key point.
With no established human safety data, the cautious reading is that unknowns dominate. Signs of an allergic reaction or spreading redness at an injection site are reasons to seek medical attention.
This page is an independent educational reference and is not medical advice. Talk to a doctor before starting any compound.